Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Renhe Pharmaceutical: Net profit of 393 million yuan in 2025, down 18.41% year-on-year
Renhe Pharmaceutical announces that in 2025, operating revenue will be 3.54B yuan, a year-on-year decrease of 13.21%; net profit will be 393 million yuan, a year-on-year decrease of 18.41%. The profit distribution plan approved by the company’s board of directors is: based on a total of 1.4 billion yuan, distribute a cash dividend of 1.5 yuan (tax included) for every 10 shares to all shareholders, issue 0 bonus shares (tax included), and do not convert capital reserves into share capital.